RxDoctor Payments Data

Cindy Marshall, MD

Geriatric Psychiatry · Dallas, TXNPI 1538199682

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Eisai Inc. accounts for 62.4% of it on its own, with 11 other manufacturers making up the rest. Among geriatric psychiatry clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$127,040in general payments, 2019–2025

Across 276 payments — averaging $460.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$79K
  • Lilly USA, LLC$34K
  • Eli Lilly$13K
  • Otsuka America Pharmaceutical, Inc.$271
  • Corium, LLC$163
  • GE HealthCare$148
  • plus $223 from 6 others

What the payments were for

  • Consulting fees$64,87051%
  • Speaking & faculty fees$43,46034%
  • Travel & lodging$13,65111%
  • Food & beverage$5,0584%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$127,040 in reported general payments places this provider in the 95th percentile of 21 geriatric psychiatry providers in Texas.

See all geriatric psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$165,340
Medicare patients
523
Services billed
1,883

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NamzaricMemantine Hcl/Donepezil Hcl20$32,934
Rivastigmine138$30,222
Memantine Hcl ErMemantine Hcl229$18,606
Donepezil Hcl1,482$18,391
Memantine Hcl546$15,642
ExelonRivastigmine11$13,070
Galantamine ErGalantamine Hbr91$5,930
Sertraline Hcl647$4,715
Quetiapine Fumarate155$2,200
Risperidone71$1,962
Mirtazapine89$1,849
RivastigmineRivastigmine Tartrate19$1,333
Escitalopram Oxalate41$651
Duloxetine Hcl20$539
Trazodone Hcl86$489

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieNamzaric$24$32,93420 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 21 geriatric psychiatry providers in Texas.

Other geriatric psychiatry in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →